Correction to Human Bile Contains MicroRNA-Laden Extracellular Vesicles That Can Be Used for Cholangiocarcinoma Diagnosis [Hepatology., 60, 896-907] DOI:10.1002/hep.27050;Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

Hepatology

Volumn 60, Issue 3, 2014, Pages 896-907

  Li, Ling ^a,b   Masica, David ^c   Ishida, Masaharu ^a   Tomuleasa, Ciprian ^a,d   Umegaki, Sho ^e   Kalloo, Anthony N ^a   Georgiades, Christos ^f,g   Singh, Vikesh K ^a   Khashab, Mouen ^a   Amateau, Stuart ^h   Li, Zhiping ^a   Okolo, Patrick ^a   Lennon, Anne Marie ^a   Saxena, Payal ^a   Geschwind, Jean Francois ^f   Schlachter, Todd ^f   Hong, Kelvin ^f   Pawlik, Timothy M ^f   Canto, Marcia ^a   Law, Joanna ^a   Sharaiha, Reem ⁱ   Weiss, Clifford R ^f   Thuluvath, Paul ^j   Goggins, Michael ^a   Shin, Eun Ji ^a   Peng, Haoran ^a   Kumbhari, Vivek ^a   Hutfless, Susan ^a   Zhou, Liya ^b   Mezey, Esteban ^a   Meltzer, Stephen J ^a   Karchin, Rachel ^c   Selaru, Florin M ^a,f   more..

^a Division of Gastroenterology Hepatology   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c Johns Hopkins University   (United States)

^d IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g American Medical Center   (Cyprus)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

^j Merry Medical Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 1274B; MICRORNA 16; MICRORNA 191; MICRORNA 19A; MICRORNA 19B; MICRORNA 21; MICRORNA 222; MICRORNA 31; MICRORNA 39; MICRORNA 484; MICRORNA 486 3P; MICRORNA 618; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE; BILE DUCT CARCINOMA; BILE LEAKAGE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CELL VACUOLE; CELL VIABILITY; CHOLANGITIS; CHOLESTASIS; COMMON BILE DUCT STONE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXTRACELLULAR VESICLE; FEMALE; FREEZE THAWING; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MATHEMATICAL MODEL; PREDICTIVE VALUE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN CONTENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BILE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; CYTOPLASMIC VESICLES; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; SUPPORT VECTOR MACHINES; YOUNG ADULT;

EID: 84906794646     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27576     Document Type: Erratum

References (25)

1. Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 2013;11:13-21.e11; quiz, e13-e14.
2. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011;8:512-522.
3. Patel T. Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol Hepatol 2011;8:189-200.
4. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009;50:791-798.
5. Scarlett CJ, Saxby AJ, Nielsen A, Bell C, Samra JS, Hugh T, et al. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology 2006;44:658-666.
6. Chapman MH, Tidswell R, Dooley JS, Sandanayake NS, Cerec V, Deheragoda M, et al. Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. J Hepatol 2011;56:877-885.
7. Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y, et al. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One 2011;6:e23584.
8. Kern SE. Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res 2012;72:6097-6101.
9. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-477.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
11. Hummel R, Hussey DJ, Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010;46:298-311.
12. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-10518.
13. Lässer C, Eldh M, Lötvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012:e3037.
14. Masica DL, Karchin R. Collections of simultaneously altered genes as biomarkers of cancer cell drug response. Cancer Res 2013;73:1699-1708.
15. Masica DL, Karchin R. Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res 2011;71:4550-4561.
16. Silverman JM, Reiner NE. Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cell Microbiol 2011;13:1-9.
17. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010;73:1907-1920.
18. Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013;21:185-191.
19. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012;7:e30679.
20. Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011;54:1237-1248.
21. Masyuk AI, Huang BQ, Ward CJ, Gradilone SA, Banales JM, Masyuk TV, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol 2010;299:G990-G999.
22. Witek RP, Yang L, Liu R, Jung Y, Omenetti A, Syn WK, et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 2009;136:320-330.e2.
23. Burdick E, Falotico-Taylor J, Young JM. Technology assessment in the Coronary Artery Surgery Study. Int J Technol Assess Health Care 1991;7:171-181.
24. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005;50:1734-1740.
25. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-207.